Exelixis (EXEL) Gross Margin (2012 - 2026)
Exelixis (EXEL) recorded Gross Margin of 96.71% in Q2 2027, up 0.14 percentage points from 96.57% a year earlier but down 0.02 percentage points from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Gross Margin (2012 - 2026) Analysis & Trends
On a TTM basis, Exelixis' Gross Margin came in at 96.48% as of Jul 3, 2026, down 0.11 percentage points year-over-year; for FY2026, it came in at 96.39%, down 0.09 percentage points from FY2025.
- Annual Gross Margin has a five-year change of +0.08 percentage points (FY2021 to FY2026).
- Across earlier years, Gross Margin came in at 96.49% in FY2025, 96.04% in FY2023 (-0.37 pp) and 96.41% in FY2022 (+0.09 pp).
- Quarterly Gross Margin has ranged from 95.00% in Q1 2025 to 97.23% in Q2 2025 over the past five years.
- On a year-over-year basis, Gross Margin rose in four of the last six quarters, with an average year-over-year change of +0.07 percentage points.
- Per Business Quant, the preceding three quarters came in at 96.73% (Q1 2027), 95.58% (Q4 2026) and 96.89% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 96.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 96.71% |
| Apr 3, 2026 | 96.73% |
| Jan 2, 2026 | 95.58% |
| Oct 3, 2025 | 96.89% |
| Jul 4, 2025 | 96.57% |
| Apr 4, 2025 | 96.55% |
| Jan 3, 2025 | 96.48% |
| Sep 27, 2024 | 96.79% |
| Jun 28, 2024 | 97.23% |
| Mar 29, 2024 | 95.00% |
| Dec 29, 2023 | 95.46% |
| Sep 29, 2023 | 96.02% |
| Jun 30, 2023 | 96.23% |
| Mar 31, 2023 | 96.50% |
| Dec 30, 2022 | 96.24% |
| Sep 30, 2022 | 96.28% |
| Jul 1, 2022 | 96.79% |
| Apr 1, 2022 | 96.29% |
| Oct 1, 2021 | 96.38% |
| Jul 2, 2021 | 96.14% |
API Access
Exelixis Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();